Phase I/II trial of combination gene and stem cell therapy for peripheral artery disease.
Status: Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 May 2014
Price : $35 *
At a glance
- Drugs Stem cell therapies (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions
- Sponsors Integene International
- 21 May 2014 This trial is expected to start in the second quarter of 2014, according to a media release.
- 21 May 2014 New trial record